Isotretinoin Research Overview
Zoretanin 20 mg is a pharmaceutical-grade isotretinoin compound, representing a 13-cis retinoic acid derivative extensively studied in dermatological research. This oral retinoid demonstrates complex mechanisms of action through retinoid receptor modulation and sebaceous gland function regulation in laboratory investigations. Researchers at Stroid UK Shop examine isotretinoin’s cellular pathways for comprehensive acne pathophysiology understanding. The compound exhibits dose-dependent effects on keratinocyte differentiation, sebum production, and inflammatory mediator expression in preclinical models. Scientific investigations focus on isotretinoin’s ability to normalise follicular epithelial desquamation and reduce Propionibacterium acnes colonisation through multiple cellular mechanisms.
Research Applications in Dermatology
Laboratory studies investigate isotretinoin’s molecular interactions with nuclear retinoid receptors, particularly RAR and RXR subtypes, which regulate gene transcription patterns in sebaceous tissue. Researchers explore the compound’s effects on sebocyte proliferation, lipid synthesis pathways, and inflammatory cascade modulation in controlled environments. Scientists studying post-cycle therapy protocols examine isotretinoin’s role in hormonal acne management and androgen-related skin responses. The pharmaceutical demonstrates significant research value in understanding comedogenesis prevention and inflammatory acne lesion formation. Contemporary research extends to isotretinoin’s immunomodulatory properties, including effects on neutrophil chemotaxis and cytokine production in dermatological models. Investigations into photoageing mechanisms and collagen synthesis regulation represent emerging research applications, while studies of isotretinoin’s interaction with selective androgen receptor modulators provide insights into hormonal dermatological pathways.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Isotretinoin (13-cis-retinoic acid) |
| Strength | 20 mg per capsule |
| CAS Number | 4759-48-2 |
| Molecular Formula | C₂₀H₂₈O₂ |
| Molecular Weight | 300.44 g/mol |
| Form | Pharmaceutical capsules |
| Storage Conditions | Room temperature, protect from light |
| Research Grade | Pharmaceutical standard |
Quality control protocols ensure consistent potency for reliable research outcomes. Each batch undergoes comprehensive analytical testing including HPLC purity analysis and stability assessments. The pharmaceutical formulation provides optimal bioavailability characteristics for in-vitro dissolution studies and pharmacokinetic research applications. Researchers investigating peptide interactions with retinoid pathways utilise these standardised preparations for accurate dose-response relationship establishment.
Research Compliance and Storage
Zoretanin 20 mg isotretinoin is supplied strictly for in-vitro laboratory research purposes and cellular pathway investigations. Storage requirements include protection from light exposure and maintenance of controlled temperature conditions to preserve compound stability. Research protocols should incorporate appropriate handling procedures and disposal methods according to laboratory safety guidelines. This pharmaceutical-grade isotretinoin enables precise research into dermatological mechanisms and retinoid receptor biology studies. The compound is not approved for human consumption and must be handled exclusively by qualified research personnel in licensed laboratory environments. All studies should comply with institutional research ethics and safety protocols.
